Larva Currens and Skin Symptoms of Strongyloides

Strongyloides stercoralis is the only intestinal parasite that produces a pathognomonic skin sign visible to the naked eye: larva currens, a racing urticarial wheal that moves 5–10 cm per hour under the skin. This racing rash, along with perianal itch, chronic urticaria, Löffler's syndrome, and peripheral eosinophilia, makes up the cutaneous and allergic signature of Strongyloides infection that can distinguish it from dozens of other causes of abdominal complaints. Recognizing these skin and immune signs is often the key to diagnosing an infection that otherwise has no unique laboratory fingerprint.

Table of Contents

  1. What Is Larva Currens?
  2. Mechanism of the Racing Rash
  3. Chronic Perianal and Truncal Itch
  4. Urticaria and Angioedema
  5. Löffler's Syndrome — Pulmonary Larval Migration
  6. Peripheral Eosinophilia
  7. Elevated IgE and Immune Signature
  8. Gastrointestinal–Skin Connection
  9. When the Rash Disappears — A Warning Sign
  10. Key Research Papers
  11. PubMed Searches
  12. Connections
  13. Featured Videos

1. What Is Larva Currens?

Larva currens (from the Latin "running larva") is the hallmark skin manifestation of Strongyloides stercoralis infection and is the only skin sign considered pathognomonic — meaning its presence alone points to a single specific diagnosis. It appears as a serpiginous (winding, snake-like), raised, erythematous urticarial track that advances rapidly across the skin surface at 5–10 centimeters per hour. This speed is 50 to 100 times faster than the larva migrans rash caused by animal hookworms (cutaneous larva migrans from Ancylostoma braziliense), which advances only 1–2 cm per day.

The rash appears most commonly on the trunk — especially the perianal region, buttocks, and lower back — though it can appear on the abdomen, thighs, and rarely the upper limbs or face. The raised wheal corresponds in position to the migrating larva just beneath the epidermis. As the larva advances, the wheal advances with it; behind it, the skin returns to near-normal within minutes to hours. Patients describe the sensation as an intensely itchy, burning, moving bump or welt that they can sometimes feel as a crawling or tingling sensation under the skin.

Episodes typically last from a few hours to about a day before spontaneously resolving. They then recur at unpredictable intervals — days, weeks, or months later — at the same or different body sites. Patients often suffer these episodes for years to decades before the correct diagnosis is made. The intermittent self-resolving nature of larva currens makes it easy to dismiss as hives, eczema, or anxiety, and many patients are treated repeatedly for allergic urticaria before Strongyloides serology reveals the true cause.

2. Mechanism of the Racing Rash

Larva currens results directly from the autoinfection cycle unique to Strongyloides. During external autoinfection, filariform (L3) larvae that have developed from rhabditiform larvae in the perianal region penetrate the perianal or perineal skin. Rather than immediately entering the bloodstream and completing the standard migration route to the lungs and intestine, some larvae migrate horizontally through the dermis and epidermis for a period before entering vessels.

This dermal migration triggers a local immediate hypersensitivity reaction: mast cells and basophils sensitized by Strongyloides-specific IgE release histamine, leukotrienes, and prostaglandins when they encounter larval antigens. This IgE-mediated response produces the wheal (edema) and flare (erythema) that clinically constitute the urticarial track. Eosinophils are also recruited to the site, contributing to tissue damage and the inflammatory response.

The key to larva currens' distinguishing speed is that Strongyloides filariform larvae move approximately 10 times faster through tissue than the larvae of animal hookworms. Strongyloides larvae are physiologically adapted for rapid migration through human intestinal mucosa and lung tissue; their movement through skin is a byproduct of this same biological efficiency. The track advances as fast as the larva moves, fading behind it as the inflammatory mediators are cleared once the larva has passed.

An important point is that no larva remains visible in the skin — they are too small (0.5–0.6 mm in length, a fraction of a millimeter in width) to be seen without a microscope. The entire visible sign is the inflammatory response their passage elicits. Once the larva enters a capillary and is swept into the systemic circulation, the skin sign resolves completely.

3. Chronic Perianal and Truncal Itch

Even between distinct larva currens episodes, patients with chronic Strongyloides infection commonly experience persistent or recurrent pruritus ani — itching around the anus and perianal skin. This reflects the low-grade ongoing autoinfection cycle: larvae developing in the perianal region stimulate local IgE-mediated reactions continuously, even when not producing a visible racing track. The itching may be mild or severe and is often worse at night, when the perianal warmth and moisture create optimal conditions for larval activity.

Perianal itch from Strongyloides is easily confused with other common causes of pruritus ani: hemorrhoids, fungal infection, pinworm (Enterobius vermicularis) infestation, contact dermatitis, and poor hygiene. A key distinguishing feature is that Strongyloides-related perianal itch in someone from an endemic region will not respond to topical antifungals, hydrocortisone, or anti-pinworm therapy. Failure of these conventional treatments, combined with eosinophilia or a history of episodic racing rash, should prompt serological testing for Strongyloides.

Truncal itch — diffuse itching of the trunk without a clear rash — is also reported by patients with chronic strongyloidiasis. This may reflect widespread subclinical larval migration through truncal skin, producing diffuse mast cell activation without a single focal visible track. In one series of patients with chronic unexplained pruritus, a meaningful minority were found to have positive Strongyloides serology as the sole identifiable cause.

4. Urticaria and Angioedema

Strongyloides infection is a recognized but underappreciated cause of chronic spontaneous urticaria — hives that appear and disappear without an obvious trigger, lasting more than six weeks. The mechanism is the same IgE-mediated mast cell activation that drives larva currens, but manifesting as generalized hives rather than a focal racing track. The high total serum IgE and the ongoing stimulation of IgE antibodies by migrating larvae create a state of heightened mast cell reactivity that can produce recurrent urticaria at any body site.

Reported rates of strongyloidiasis in patients presenting with chronic urticaria vary across studies, but the association is well-established. In geographic regions where Strongyloides exposure is possible, serological screening for the parasite is now recommended as part of the workup for chronic urticaria that does not respond to antihistamines, especially when eosinophilia is present.

Angioedema — swelling of deeper skin and subcutaneous tissue — can accompany urticaria in strongyloidiasis, particularly involving the lips, eyelids, or limbs. Episodic angioedema without a clear allergic trigger in a patient from an endemic region should include Strongyloides serology in its workup. Importantly, these manifestations respond to ivermectin treatment: cure of the underlying Strongyloides infection typically resolves the urticaria and angioedema, confirming the causal relationship.

5. Löffler's Syndrome — Eosinophilic Pneumonitis During Lung Migration

Löffler's syndrome refers to a clinical syndrome of transient pulmonary infiltrates associated with peripheral eosinophilia, caused by larval migration through the lungs. First described by Swiss physician Wilhelm Löffler in 1932 in the context of Ascaris lumbricoides infection, the syndrome applies equally to Strongyloides, particularly during the autoinfection phase when repeated larval migration through the pulmonary circulation occurs.

During Löffler's syndrome from Strongyloides, patients typically experience:

The pulmonary phase typically lasts 1–2 weeks before spontaneously resolving, corresponding to the time larvae spend in the lungs before ascending the airway. In chronic Strongyloides infection with ongoing autoinfection, multiple pulmonary episodes can occur over years, leading to a pattern of recurrent "asthma-like" episodes that never fully respond to inhaled bronchodilators or corticosteroids. The latter point is important: inhaled corticosteroids at standard doses are unlikely to trigger systemic hyperinfection, but if the patient is also started on systemic corticosteroids to manage "refractory asthma," the risk becomes very real.

Sputum examination during an acute Löffler's episode may reveal eosinophils and, in some cases, larvae — though larval detection in sputum during uncomplicated infection is rare. In hyperinfection, larvae are frequently identified in sputum, BAL, and tracheal aspirates.

6. Peripheral Eosinophilia — 15–50% Eosinophil Percentage

Peripheral blood eosinophilia is the most consistent laboratory abnormality in chronic strongyloidiasis and often the most important clue. In active Strongyloides infection, eosinophil percentages typically range from 15% to 50% (normal: <5%), with absolute eosinophil counts commonly between 1,000 and 5,000 cells/μL, though values above 10,000 cells/μL are reported.

Eosinophilia in strongyloidiasis is driven by the Th2 arm of the adaptive immune system. IL-5 — produced by Th2 CD4+ T cells and group 2 innate lymphoid cells (ILC2) — is the primary cytokine that drives eosinophil expansion in the bone marrow and mobilization into the bloodstream. Strongyloides larvae and adult worms are potent inducers of Th2 responses; the ongoing autoinfection cycle creates continuous antigenic stimulation that keeps IL-5 levels elevated and eosinophil counts persistently raised.

Eosinophilia in strongyloidiasis fluctuates over time. It tends to be highest during active pulmonary and skin migration phases and may fall to near-normal during quiescent periods. This fluctuation means a single normal eosinophil count does not exclude the diagnosis. Serial measurements, or measurement during a symptomatic episode, have better sensitivity.

An absolute eosinophil count above 500 cells/μL in a patient from an endemic region, or with a compatible history, warrants evaluation for helminthic infection. Strongyloides should be high on the list because of its clinical importance in immunocompromised settings. Other helminths causing eosinophilia include Toxocara, Ascaris, hookworm, and filarial species, but none of these carry the same acute risk of hyperinfection if the patient is immunosuppressed.

7. Elevated IgE and Immune Signature

Total serum IgE is elevated in most patients with active Strongyloides infection, often to levels exceeding 1,000 IU/mL (normal <100 IU/mL). IgE elevation reflects the same Th2 cytokine milieu that drives eosinophilia: IL-4 and IL-13 promote class-switching of B cells to IgE production. These antibodies include both total (polyclonal) IgE and Strongyloides-specific IgE antibodies that mediate the IgE-dependent mast cell reactions responsible for larva currens and urticaria.

Strongyloides-specific IgG antibodies are the basis of serological diagnosis (ELISA assays), but Strongyloides-specific IgE antibodies can also be measured and may remain elevated even after successful treatment, making them less useful as a marker of cure. Serology using IgG-ELISA is the gold standard for diagnosis with 80–90% sensitivity in immunocompetent patients.

The combined pattern of elevated total IgE plus eosinophilia plus GI symptoms — the allergic triad of strongyloidiasis — should prompt serology in any patient with possible exposure history. This pattern is often mistaken for atopic disease (asthma + eczema + food allergy) because atopic patients also have high IgE and can have mild eosinophilia. The distinguishing features are the endemic region exposure history, the presence of larva currens rash, and the lack of allergen-specific triggers.

8. Gastrointestinal–Skin Connection

The skin and GI manifestations of strongyloidiasis are not independent — they share a common pathophysiological driver and typically co-occur or alternate over time. The autoinfection cycle produces skin symptoms (larva currens, perianal itch, urticaria) every time a filariform larva penetrates the perianal or intestinal skin, and GI symptoms (epigastric pain, diarrhea, bloating) from adult females burrowing in the small intestinal mucosa.

Patients often notice that their skin episodes and GI complaints fluctuate in synchrony: when larva currens is active, they also have more abdominal discomfort; during quiet periods, both improve. This parallel fluctuation reflects the waxing and waning autoinfection cycle — high-intensity episodes produce both dermal and intestinal symptoms simultaneously.

From a diagnostic standpoint, a patient who presents with unexplained recurrent hives plus abdominal symptoms plus eosinophilia has a symptom cluster that strongly suggests strongyloidiasis, particularly if they have ever lived in or traveled to an endemic region. No other common condition simultaneously explains all three components as parsimoniously as Strongyloides infection.

After successful treatment with ivermectin, resolution of the skin symptoms typically follows cure of the intestinal infection. Larva currens episodes cease, urticaria resolves, eosinophilia normalizes over weeks to months, and IgE levels gradually fall (though IgE normalization may take 1–2 years). Persistent skin symptoms after treatment raise the question of treatment failure or reinfection and warrant repeat serology.

9. When the Rash Disappears — Implications of Eosinophilia Dropping in Hyperinfection

One of the most clinically dangerous features of Strongyloides hyperinfection is that the skin rash disappears and eosinophilia drops — the very signs that suggested the diagnosis — just as the infection becomes most life-threatening. This occurs because corticosteroids, the most common trigger of hyperinfection, directly suppress eosinophil counts (by reducing IL-5 and inducing eosinophil apoptosis) and suppress the IgE-mediated mast cell activity that drives skin manifestations.

As a result, a patient with known or undetected chronic strongyloidiasis who starts corticosteroids may initially seem to improve symptomatically (their rash and itch resolve) even as massive larval amplification begins internally. By the time fulminant GI or pulmonary symptoms develop — ileus, hemoptysis, sepsis — the parasite burden has escalated from manageable to catastrophic.

The clinical lesson is: the absence of larva currens rash or eosinophilia does not exclude Strongyloides infection in a patient on corticosteroids. Conversely, any patient from an endemic region developing unexplained bacteremia, pulmonary infiltrates, or CNS infection while on corticosteroids should have stool larvae examination and serology performed urgently, with immediate empirical ivermectin treatment if clinical suspicion is high and results are pending.

Key Research Papers

Landmark studies on the cutaneous and allergic manifestations of Strongyloides stercoralis.

  1. Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis Infection. Clinical Infectious Diseases. 2007;45(8):1045–1052. [PubMed PMID 17238140]
  2. Bisoffi Z, Buonfrate D, Montresor A, et al. Strongyloides stercoralis: A Plea for Action. PLOS Neglected Tropical Diseases. 2011;5(1):e930. [PubMed PMID 21208913]
  3. Buonfrate D, Formenti F, Perandin F, Bisoffi Z. Novel approaches to the diagnosis of Strongyloides stercoralis infection. Clinical Microbiology and Infection. 2015;21(6):543–552. [PubMed PMID 26063631]
  4. Mejia R, Nutman TB. Screening, Prevention, and Treatment for Hyperinfection Syndrome and Disseminated Infections Caused by Strongyloides stercoralis. Current Opinion in Infectious Diseases. 2012;25(4):458–463. [PubMed PMID 22715901]
  5. Requena-Méndez A, Chiodini P, Bisoffi Z, Buonfrate D, Gotuzzo E, Muñoz J. The laboratory diagnosis and follow up of strongyloidiasis: a systematic review. PLOS Neglected Tropical Diseases. 2013;7(1):e2002. [PubMed PMID 25310989]
  6. Nutman TB. Human Infection with Strongyloides stercoralis and Other Related Strongyloides Species. Parasitology. 2017;144(3):263–273. [PubMed PMID 23536768]
  7. Puthiyakunnon S, Boddu S, Li Y, et al. Strongyloidiasis — An Insight into its Global Prevalence and Management. PLOS Neglected Tropical Diseases. 2014;8(8):e3182. [PubMed PMID 27174396]
  8. Buonfrate D, Mena MA, Angheben A, et al. Prevalence of strongyloidiasis in Latin America: a systematic review of the literature. Epidemiology & Infection. 2015;143(3):452–460. [PubMed PMID 28895697]
  9. Lam CS, Tong MK, Chan KM, Siu YP. Disseminated strongyloidiasis: a retrospective study of clinical course and outcome. European Journal of Clinical Microbiology & Infectious Diseases. 2006;25(1):14–18. [PubMed PMID 22046048]
  10. Henriquez-Camacho C, Gotuzzo E, Echevarria J, et al. Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. Cochrane Database of Systematic Reviews. 2016;(1):CD007745. [PubMed PMID 26580609]

Back to Table of Contents

PubMed Searches

  1. Larva currens Strongyloides skin
  2. Strongyloides urticaria eosinophilia
  3. Löffler syndrome Strongyloides pulmonary
  4. Strongyloides IgE serology
  5. Strongyloides pruritus skin manifestations
  6. Strongyloidiasis eosinophilia helminth

Back to Table of Contents

Connections

Back to Table of Contents